Literature DB >> 7684769

Acute phase reactants and severity of homozygous sickle cell disease.

C C Hedo1, Y A Aken'ova, I E Okpala, A O Durojaiye, L S Salimonu.   

Abstract

Serum concentrations of seven acute-phase reactants: albumin, transferrin (Tf), alpha-1-antitrypsin (AIAT), caeruloplasmin (Cp), alpha 2-macroglobulin (alpha 2-MG), haptoglobin (hp) and C-reactive protein (CRP) were determined in 73 subjects with varying severities of homozygous sickle cell (HbSS) disease. Fifty healthy subjects of comparable sex, age and socio-economic class distributions as the HbSS subjects served as controls. Albumin and alpha 2-MG were comparable in all the subject groups. Tf and hp levels were significantly reduced in the HbSS groups relative to the control group. Conversely, AIAT, CRP and CP were significantly elevated. However only Tf and CRP manifested significant correlations with any of the indices of disease severity employed. Transferrin and CRP are suggested as plasma proteins worthy of further evaluation as indicators of severity in homozygous sickle cell disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7684769     DOI: 10.1111/j.1365-2796.1993.tb01000.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  21 in total

1.  Polysomnographic characteristics of a referred sample of children with sickle cell disease.

Authors:  Valerie E Rogers; Daniel S Lewin; Glenna B Winnie; Jeanne Geiger-Brown
Journal:  J Clin Sleep Med       Date:  2010-08-15       Impact factor: 4.062

2.  Oxidative stress and inflammation in iron-overloaded patients with beta-thalassaemia or sickle cell disease.

Authors:  Patrick B Walter; Ellen B Fung; David W Killilea; Qing Jiang; Mark Hudes; Jacqueline Madden; John Porter; Patricia Evans; Elliott Vichinsky; Paul Harmatz
Journal:  Br J Haematol       Date:  2006-10       Impact factor: 6.998

Review 3.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

4.  Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Authors:  Vimal K Derebail; Eduardo K Lacson; Abhijit V Kshirsagar; Nigel S Key; Susan L Hogan; Raymond M Hakim; Ann Mooney; Chinu M Jani; Curtis Johnson; Yichun Hu; Ronald J Falk; J Michael Lazarus
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

Review 5.  Measurement and analysis of unbound drug concentrations.

Authors:  J D Wright; F D Boudinot; M R Ujhelyi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

6.  Periodic limb movements and disrupted sleep in children with sickle cell disease.

Authors:  Valerie E Rogers; Carole L Marcus; Abbas F Jawad; Kim Smith-Whitley; Kwaku Ohene-Frempong; Cheryl Bowdre; Julian Allen; Raanan Arens; Thornton B A Mason
Journal:  Sleep       Date:  2011-07-01       Impact factor: 5.849

Review 7.  Rheumatological manifestations of haematological diseases.

Authors:  S Menon; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

8.  Serum haptoglobin and hemopexin levels are depleted in pediatric sickle cell disease patients.

Authors:  Rayra Pereira Santiago; Caroline Conceição Guarda; Camylla Vilas Boas Figueiredo; Luciana Magalhaes Fiuza; Milena Magalhães Aleluia; Corynne Stephanie Ahouefa Adanho; Magda Oliveira Seixas Carvalho; Thassila Nogueira Pitanga; Dalila Luciola Zanette; Isa Menezes Lyra; Valma Maria Lopes Nascimento; Gregory M Vercellotti; John D Belcher; Marilda Souza Goncalves
Journal:  Blood Cells Mol Dis       Date:  2018-07-19       Impact factor: 3.039

9.  Methacholine challenge in children with sickle cell disease: a case series.

Authors:  Robert C Strunk; Michael Scott Brown; Jessica H Boyd; Pamela Bates; Joshua J Field; Michael R DeBaun
Journal:  Pediatr Pulmonol       Date:  2008-09

10.  Increased levels of the inflammatory biomarker C-reactive protein at baseline are associated with childhood sickle cell vasocclusive crises.

Authors:  Suba Krishnan; Yamaja Setty; Suhita G Betal; Vaidyula Vijender; Koneti Rao; Carlton Dampier; Marie Stuart
Journal:  Br J Haematol       Date:  2009-12-08       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.